REC-1/STAT3 Reporter (Luc) stable cell line
REC-1/STAT3 Reporter (Luc) cells are derived from the human B-cell lymphoma cell line REC-1 by stably integration of a STAT3 firefly luciferase reporter construct. REC-1 is derived from a patient with mantle cell lymphoma (MCL), making it a valuable model for studying this specific type of lymphoma. REC-1 cells are used to investigate the molecular pathways involved in MCL pathogenesis, including the role of cyclin D1 in cell cycle regulation, as well as to evaluate the efficacy of new therapeutic agents, including chemotherapy and targeted therapies. REC-1/STAT3 Reporter (Luc) cells stably express firefly luciferase under the control of the STAT3 response elements, can be used for monitoring the activity of STAT3 signaling pathway.
Product Specifications
No additional specifications available.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CDK5 (Cyclin-Dependent Kinase 5, Cell Division Protein Kinase 5, Serine/Threonine-protein Kinase PSSALRE, Tau Protein Kinase II Catalytic Subunit, TPKII Catalytic Subunit) (FITC)
